Mark Austin
Director of Finance/CFO at PERSPECTIVE THERAPEUTICS, INC.
Net worth: 134 448 $ as of 2024-04-29
Mark Austin active positions
| Companies | Position | Start | End |
|---|---|---|---|
| PERSPECTIVE THERAPEUTICS, INC. | Comptroller/Controller/Auditor | 2017-06-30 | - |
| Director of Finance/CFO | 2017-06-30 | - | |
| Corporate Secretary | 2020-09-14 | - |
Career history of Mark Austin
Former positions of Mark Austin
| Companies | Position | Start | End |
|---|---|---|---|
KPMG Advisory SP ZOO Spolka Komandytowa
 KPMG Advisory SP ZOO Spolka Komandytowa Investment ManagersFinance Part of KPMG CEE Holdings Ltd., KPMG Advisory Sp zoo Spolka Komandytowa provides financial advisory services. The company is based in Warsaw, Poland. | Corporate Officer/Principal | 2008-12-31 | 2017-06-30 |
IsoRay, Inc.
 IsoRay, Inc. Medical SpecialtiesHealth Technology IsoRay, Inc. is a medical technology company, which engages in the development, manufacture, and sale of isotope-based medical products and devices. The firm focuses on the treatment of cancer and other malignant diseases. Its core product is Cesium-131, a radioisotope for the treatment of malignant tumors. The company was founded by Lance A. Bray in 1983 and is headquartered in Richland, WA. | Comptroller/Controller/Auditor | 2017-07-23 | - |
| Director of Finance/CFO | 2017-07-23 | - | |
| Corporate Secretary | 2018-12-02 | - |
Training of Mark Austin
| Santa Clara University | Undergraduate Degree |
Statistics
International
| United States | 4 |
| Poland | 2 |
Operational
| Comptroller/Controller/Auditor | 2 |
| Director of Finance/CFO | 2 |
| Corporate Secretary | 2 |
Sectoral
| Health Technology | 3 |
| Consumer Services | 2 |
| Finance | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| PERSPECTIVE THERAPEUTICS, INC. | Health Technology |
| Private companies | 2 |
|---|---|
IsoRay, Inc.
IsoRay, Inc. Medical SpecialtiesHealth Technology IsoRay, Inc. is a medical technology company, which engages in the development, manufacture, and sale of isotope-based medical products and devices. The firm focuses on the treatment of cancer and other malignant diseases. Its core product is Cesium-131, a radioisotope for the treatment of malignant tumors. The company was founded by Lance A. Bray in 1983 and is headquartered in Richland, WA. | Health Technology |
KPMG Advisory SP ZOO Spolka Komandytowa
KPMG Advisory SP ZOO Spolka Komandytowa Investment ManagersFinance Part of KPMG CEE Holdings Ltd., KPMG Advisory Sp zoo Spolka Komandytowa provides financial advisory services. The company is based in Warsaw, Poland. | Finance |
- Stock Market
- Insiders
- Mark Austin
- Experience
